EcoDrugPlus

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSPKIG00000002622
Gene Symbol: HSP90AB1
3 Cross references
339 Possible Orthologues:

Hepatocyte Growth Factor Receptor-Like

Ensembl ID : ENSPKIG00000008429
Gene Symbol: LOC111836018
3 Cross references
204 Possible Orthologues:

High Affinity Camp-Specific 3',5'-Cyclic Phosphodiesterase 7a-Like

Ensembl ID : ENSPKIG00000008071
Gene Symbol: LOC111834849
3 Cross references
227 Possible Orthologues:

High Affinity Nerve Growth Factor Receptor-Like

Ensembl ID : ENSPKIG00000020463
Gene Symbol: LOC111853509
3 Cross references
197 Possible Orthologues:

High Mobility Group Box 1a

Ensembl ID : ENSPKIG00000015949
Gene Symbol: HMGB1A
1 Cross references
511 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSPKIG00000024898
Gene Symbol: HRH1
4 Cross references
186 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSPKIG00000017130
Gene Symbol: HRH2A
1 Cross references
182 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSPKIG00000011830
Gene Symbol: HDAC1
4 Cross references
308 Possible Orthologues:

Histone Deacetylase 1-Like

Ensembl ID : ENSPKIG00000024744
Gene Symbol: LOC111854208
3 Cross references
307 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSPKIG00000022112
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSPKIG00000004742
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSPKIG00000018988
Gene Symbol: HDAC2
4 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).